National Bank of Canada’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.6K | Buy |
263
+91
| +53% | +$26.1K | ﹤0.01% | 1542 |
|
|
2025
Q1 | $53K | Sell |
172
-2
| -1% | -$616 | ﹤0.01% | 1563 |
|
|
2024
Q4 | $61.5K | Buy |
174
+12
| +7% | +$4.24K | ﹤0.01% | 1527 |
|
|
2024
Q3 | $58K | Sell |
162
-24
| -13% | -$8.6K | ﹤0.01% | 1489 |
|
|
2024
Q2 | $59.3K | Sell |
186
-33
| -15% | -$10.5K | ﹤0.01% | 1491 |
|
|
2024
Q1 | $57.9K | Sell |
219
-21,312
| -99% | -$5.63M | ﹤0.01% | 1523 |
|
|
2023
Q4 | $4.89M | Sell |
21,531
-19,637
| -48% | -$4.46M | 0.01% | 672 |
|
|
2023
Q3 | $9.15M | Buy |
41,168
+23,956
| +139% | +$5.32M | 0.01% | 513 |
|
|
2023
Q2 | $3.85M | Buy |
17,212
+12,936
| +303% | +$2.89M | 0.01% | 702 |
|
|
2023
Q1 | $963K | Buy |
4,276
+4,071
| +1,986% | +$917K | ﹤0.01% | 972 |
|
|
2022
Q4 | $57K | Sell |
205
-3,719
| -95% | -$1.03M | ﹤0.01% | 1556 |
|
|
2022
Q3 | $839K | Buy |
3,924
+3,764
| +2,353% | +$805K | ﹤0.01% | 905 |
|
|
2022
Q2 | $38K | Sell |
160
-5,982
| -97% | -$1.42M | ﹤0.01% | 1649 |
|
|
2022
Q1 | $1.1M | Buy |
6,142
+6,000
| +4,225% | +$1.08M | ﹤0.01% | 893 |
|
|
2021
Q4 | $31K | Buy |
+142
| New | +$31K | ﹤0.01% | 1820 |
|